As everyone knows, half yearly results will be released on Wednesday night before trading starts. Revenue from the 17 university hospitals that have supposedly been onboarded didn't seem to show up in the December 2020 full year numbers despite the initial announcement from July 2020 saying that revenue would be progressively booked over the next 90 days from the first 4 hospitals. If revenue is still stuck at around 2 to 2.5 million for the half year, it will indicate that the 17 university hospitals deal was, to be polite, a dud. The company didn't need the NASDAQ IPO funds to onboard these hospitals. They had already implemented 10 by August 2020 and another 7 were in the pipeline. I'm just throwing this out there as a brief history that people might have some thoughts about. If the university hospital deals were real, we should be seeing revenue doubling or tripling from the previous half year. Will the company finally deliver something other than disappointment?
- Forums
- ASX - By Stock
- GMV
- GMVD Nasdaq
GMVD Nasdaq, page-62
-
-
- There are more pages in this discussion • 766 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CC9
CHARIOT CORPORATION LTD
MD - Shanthar Pathmanathan, Geologist - David Trabert
MD - Shanthar Pathmanathan
Geologist - David Trabert
SPONSORED BY The Market Online